MetaVia is trading 5.01% up now at $1.49, moving higher alongside a broader risk-on session after July CPI showed inflation at 3.4% year over year and reduced expectations for a near-term Federal Reserve rate hike.
- No fresh company-specific announcement was found on August 12, 2026.
- MetaVia’s August 6 quarterly update and clinical progress remain recent background, but available evidence points primarily to global market sentiment.